The IOZK is a translational center that develops immuno-oncology procedures based on new scientific findings.

These are combined individually for each patient in the best possible way. For this reason, no randomized clinical trials are conducted at the IOZK. These require the same treatment protocol for all patients in the experimental group and a control group that does not receive treatment. In science, new methods of investigation are being developed and discussed that are better suited to studying the effectiveness of highly individualized therapy. It is very important to us to contribute to scientific progress and the development of modern immunotherapy for tumor diseases.

Here we provide scientific papers published by IOZK staff members.